Position in BMRN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$223,832,852
+$8,072,631 QoQ
Shares Held
3,911,794
+2.4% QoQ
Ownership
2.02%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#13
of 561 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,415,676 across 520 Biotechnology names. BMRN ranks #21 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in BMRN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $223,832,852 | 3,911,794 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $215,760,221 | 3,819,441 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $218,351,109 | 3,674,089 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $191,841,218 | 3,542,120 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $190,989,855 | 3,474,438 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $242,555,274 | 3,431,253 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $216,171,377 | 3,288,778 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $229,148,913 | 3,260,050 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $263,403,143 | 3,199,358 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $260,859,688 | 2,986,715 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $276,959,893 | 2,872,432 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $244,420,337 | 2,762,436 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $234,991,647 | 2,711,025 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $258,864,840 | 2,662,123 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $267,428,922 | 2,584,104 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $213,156,114 | 2,514,523 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $204,839,391 | 2,471,816 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $189,221,672 | 2,454,237 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $211,981,954 | 2,399,343 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $179,535,704 | 2,322,884 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $192,656,451 | 2,308,922 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $163,709,077 | 2,168,045 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $180,390,693 | 2,057,141 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $151,233,040 | 1,987,816 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $257,094,335 | 2,084,436 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $175,953,758 | 2,082,293 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||